Synopsis of recent research by authors named "Renzhi Han"
- Renzhi Han's recent research primarily focuses on advanced gene and epigenome editing technologies, emphasizing their rapidly evolving nature and their implications for biomedical research and therapeutic development, as detailed in articles like "Rapidly evolving genome and epigenome editing technologies."
- A significant portion of Han's work addresses Duchenne muscular dystrophy (DMD), including innovative strategies to deliver full-length dystrophin to muscle tissues and targeting microRNAs to improve treatment responses, showcasing findings in "Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice."
- Han also explores the development of therapeutic approaches for lipid metabolism and cardiovascular health using gene editing techniques, as demonstrated in studies like "Liver-specific in vivo base editing of Angptl3 via AAV delivery efficiently lowers blood lipid levels in mice," indicating a broader implication of his research in metabolic disorders.
